Altimmune to Showcase Innovations at Key Investor Conferences

Altimmune's Upcoming Investor Conferences

Altimmune, Inc. is gearing up for two notable investor conferences where members of the management team will be available for discussions. This presents a fantastic opportunity for investors and stakeholders to gain insights into the company’s exciting developments.

Annual Evercore HealthCONx Conference

On a significant day dedicated to healthcare discussions, Altimmune will participate in the Annual Evercore HealthCONx Conference. This event is scheduled to take place in Coral Gables, Florida. The company will engage in a Fireside Chat, delivering key insights into their operations and future directions. This chat will commence at 10:50 a.m. Eastern Time, aiming to attract significant attention from conference attendees.

Piper Sandler Annual Healthcare Conference

Following shortly after, Altimmune will also participate in the Piper Sandler Annual Healthcare Conference in New York. This event is poised to further highlight Altimmune’s commitment to its advancements in biopharmaceuticals. The Fireside Chat at this conference will occur at 3:30 p.m. Eastern Time, providing yet another platform for the company to showcase its dedication to innovation and transparency in the healthcare sector.

Webcast Access for Participants

Investors and interested parties can access the webcasts of these sessions through the Events section on Altimmune's website. This accessibility ensures that stakeholders can stay informed about the latest developments with the company, strengthening community engagement and investor relations.

Innovative Developments by Altimmune

Building on its reputation as a clinical-stage biopharmaceutical company, Altimmune focuses on developing next-generation peptide-based therapeutics. One of the significant advancements includes pemvidutide, a GLP-1/glucagon dual receptor agonist tailored for treating obesity and metabolic conditions. As the healthcare landscape continues to evolve, Altimmune is positioning itself at the forefront of innovative treatments that aim to address pressing health challenges.

Commitment to Transparency and Communication

Altimmune emphasizes its commitment to transparency and open communication with its investors and stakeholders. The management team’s participation in these conferences is part of its broader strategy to keep everyone informed about the company’s progress and the impact of its therapeutic developments.

Staying Connected with Altimmune

For those interested in following Altimmune’s journey, they can connect on various social media platforms, including LinkedIn and Twitter, where updates and insights are regularly shared. This digital presence allows stakeholders immediate access to company news and announcements.

Company Contact Information

Altimmune encourages any inquiries related to investor relations or further information to be directed to their Chief Financial Officer, Greg Weaver. He can be reached at 240-654-1450. Additionally, for specific investor queries, Lee Roth from Burns McClellan is available at 646-382-3403. Media inquiries can be sent to Danielle Cantey via phone at 619-826-4657.

Frequently Asked Questions

What is Altimmune known for?

Altimmune is recognized for its innovative development of peptide-based therapeutics aimed at treating obesity and metabolic disorders.

Where will Altimmune present next?

Altimmune will participate in the Annual Evercore HealthCONx Conference and the Piper Sandler Annual Healthcare Conference.

How can I access the presentations?

Webcasts of the presentations can be accessed through the Events section on Altimmune's website.

What is pemvidutide?

Pemvidutide is Altimmune's GLP-1/glucagon dual receptor agonist, targeting obesity and metabolic diseases.

How can I contact Altimmune?

To reach Altimmune, you can contact Greg Weaver, CFO, at 240-654-1450 for investor-related inquiries.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.